< Key Hightlight >

MARKET OUTLOOK

Triton’s research report alludes that the Middle East and Africa’s infertility testing and treatment market is envisioned to advance at a CAGR of 9.43% during the estimated years 2021-2028. The UAE, Turkey, Saudi Arabia, South Africa, and Rest of Middle East & Africa form the market in the given region.

Over the years, there has been a substantial decline in the fertility rate across Saudi Arabia. This is mainly owing to the high cost of living, economic conditions, and delay in marriage in the country. Furthermore, more than 20,000 IVF treatment cycles are conducted each year across ART centers within the country. Additionally, the country is emerging as an attractive destination for infertility treatments, owing to the reasonable costs of IVF treatment. These developments are likely to enhance the demand for infertility treatments across the country. Therefore, these factors are likely to stimulate the infertility testing and treatment market’s growth within Saudi Arabia in the upcoming days. 

Furthermore, infertility is a major reproductive health issue arising in South Africa. According to the United Nations, the country’s average fertility rate is declining and is anticipated to decrease in the upcoming years. Factors such as poor access to assisted reproductive technologies, along with proper healthcare facilities, are majorly impacting the development of the studied market. Furthermore, a constant surge in the cases of infertility and associated diseases among the population adds to the demand for infertility treatment. Hence, these factors are expected to generate several opportunities for the infertility testing and treatment market within South Africa. 

COMPETITIVE OUTLOOK

The leading companies in the infertility testing and treatment market are Cook Medical Inc, Create Fertility Centre, EMD Group (Merck KGAA), Endo International Plc, Vitrolife AB, Halotech DNA, and Bangkok IVF Center.